Adenosine monophosphate-activated protein kinase gamma-3-containing heterotrimer (AMPK gamma-3 heterotrimer)

Adenosine monophosphate-activated protein kinase (AMPK) is a heterotrimeric enzyme complex consisting of a catalytic alpha subunit and regulatory beta and gamma subunits. The gamma-3 (γ3) isoform is uniquely and highly expressed in skeletal muscle, where it forms specific heterotrimeric complexes (typically α2β2γ3) that play a critical role in sensing energy status during exercise and contraction (UniProt: Q9UGI9). These heterotrimers are activated by increases in the AMP:ATP ratio, leading to the stimulation of glucose uptake and fatty acid oxidation to restore cellular energy levels (PubMed: 15123708). Because of its muscle-specific expression, the AMPK γ3-containing heterotrimer is a high-priority therapeutic target for treating Type 2 diabetes and insulin resistance, as its activation can bypass insulin signaling to lower blood glucose (PubMed: 12610022). Drugs like MK-8722 have been developed as potent activators of all AMPK isoforms, including γ3, to improve metabolic health in preclinical models (PubMed: 28794288). However, achieving tissue specificity remains a challenge to avoid potential side effects in the heart or liver associated with other gamma isoforms (PubMed: 29141912).

Other names

PRKAG3-containing AMPKAMP-activated protein kinase gamma-3 complexSkeletal muscle-specific AMPK5'-AMP-activated protein kinase subunit gamma-3 heterotrimer

Direct allosteric activation of the enzyme complex and protection of the catalytic alpha-subunit from dephosphorylation at the Thr172 site, leading to increased phosphorylation of downstream metabolic targets like Acetyl-CoA Carboxylase (ACC).